Social Impact and Quality of Life of Patients with β-Thalassaemia: A Systematic Review
β-Thalassaemia (BT) is a hereditary genetic blood disease caused by a mutation in the gene that encodes the haemoglobin protein. In the most severe forms, BT forces patients to undergo frequent blood transfusions, which has a significant impact on the quality of life. Classified as rare, BT is very...
Main Authors: | Francesca Greco, Franca Marino |
---|---|
Format: | Article |
Language: | English |
Published: |
European Medical Journal
2022-04-01
|
Series: | European Medical Journal Hematology |
Online Access: | https://www.emjreviews.com/hematology/article/social-impact-and-quality-of-life-of-patients-with-%ce%b2-thalassaemia-a-systematic-review/ |
Similar Items
-
SLEEP QUALITY IN PATIENTS WITH Β-THALASSAEMIA MAJOR
by: Ali Özdemir, et al.
Published: (2023-10-01) -
The impact of chelation compliance in health outcome and health related quality of life in thalassaemia patients: a systematic review
by: Wan Jin Lee, et al.
Published: (2024-02-01) -
Review of endocrine complications in adult patients with β-thalassaemia major
by: Ploutarchos Tzoulis
Published: (2014-12-01) -
Quality of life in transfusion-dependent thalassaemia patients on desferrioxamine treatment
by: Dahlui, M., et al.
Published: (2009) -
Current and Future Therapies for β-Thalassaemia: A Review Article
by: Livia Giannoni, et al.
Published: (2021-07-01)